Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role Of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis in Very Low Birth Weight Infants

NCT01531179 is registered in ClinicalTrials.gov with Zekai Tahir Burak Women's Health Research and Education Hospital as lead sponsor.

NCT NCT01531179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01531179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role Of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis in Very Low Birth Weight Infants
Lead sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2012
Completion date
February 28, 2013
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

necrotizing enterocolitis, very low birth weight infants